Table 1.
Demographic and Oral Intake Pre- and Post-Gabapentin.
Sex | Age (Months) | Gestational Age (Weeks) | Diagnosis | Pre (mL) | Post (mL) |
---|---|---|---|---|---|
Female | 1.5 | Unavailable | TGV | 1514 | 1498 |
Male | 12 | 39 | ASD, TGV | 0 | 23 |
Female | 2 | 36 | Heart block | 1046 | 1655 |
Female | 2 | 37 | ASD, VSD | 149 | 420 |
Female | 2 | 40 | HLH | 211 | 568 |
Male | 1.3 | 42 | Hypoplastic aortic arch | 128 | 214 |
Female | 1.5 | 38 | VSD, TA | 562 | 1303 |
Male | 1 | 39 | TOF, PA | 416 | 1520 |
Male | 2 | 39 | TGA, TA, VSD | 212 | 1030 |
Female | 2 | 37 | PA, VSD, ASD, Ebstein’s anomaly | 306 | 1230 |
Male | 1.5 | 39 | TGA, PA, VSD | 1044 | 1165 |
Female | 1.5 | 37 | HLH | 51 | 145 |
Male | 1 | 39 | HLH | 127 | 310 |
Female | 3 | 31 | TOF, PA | 227 | 622 |
Female | 2.5 | 38 | HLH | 27 | 25 |
Abbreviations: TGV, transposition of the great vessels; ASD, atrial septal defect; VSD, ventricular septal defect; HLH, hypoplastic left heart; TOF, tetralogy of Fallot; TGA, transposition of the great arteries; TA, tricuspid atresia; PA, pulmonary valve atresia.